Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
222.00    -5.00 (-2.20%)
Bid:
222.00
Ask:
232.00
Spread: 10.00 (4.505%)
Market Cap: £117.21m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

30 Oct 2014 07:00

RNS Number : 6537V
Microgen PLC
30 October 2014
 



microgen

www.microgen.com 30 October 2014

 

INTERIM MANAGEMENT STATEMENT

 

Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 July 2014 to the date of this announcement. Microgen released its interim results for the six months ended 30 June 2014 on 21 July 2014.

 

There have been no significant changes since 1 July 2014 in the trading or financial position of Microgen and its balance sheet remains strong. Both of the Group's businesses, Aptitude Software and Financial Systems, continue to perform satisfactorily in line with the Board's current expectations. In line with the Group's seasonal cash flow cycle and the normal variation in timing of customer receipts the Group had cash at 30 September 2014 of £34.7 million (30 June 2014: £37.9 million) and net funds of £17.7 million (30 June 2014: £20.2 million).

 

Investment has continued in the Aptitude Software business with the release of the latest version of the Aptitude technology platform in October. This software version further extends the Aptitude Big Data processing capabilities enabling users to build data-driven applications deploying Aptitude's in-memory, in-database and in-Hadoop processing. In conjunction with this release, the Aptitude Software business has entered into a partnership with Cloudera, the leading distributor of Apache Hadoop. In October, the Aptitude Software business also released the Compact Edition of the Aptitude Accounting Hub, a pre-configured Aptitude-based divisional accounting hub and sub-ledger which complements the Aptitude Revenue Recognition Engine and the Aptitude Allocation Engine released earlier in the year.

 

In August, Aptitude Software signed a contract with a large North American telecommunications company, which is anticipated to generate revenues in excess of $5 million over its expected term. Discussions are also underway with a number of other telecommunications companies related to the potentially very high volume data processing demands associated with the new IFRS 15 (customer contract revenue recognition) accounting requirements.

 

Financial Systems' wealth management product for trust and fund administration, 5Series, continues to be well received in the market with three new contracts entered into since 1 July 2014. In line with the Board's strategy, the Financial Systems' Application Management business continues to decline slowly as some legacy products/solutions approach end of life. A number of add-on acquisitions in the wealth management sector continue to be progressed, although the Board remains prudent and, as always, there can be no certainty that any acquisitions will be completed.

 

Microgen is continuously identifying and evaluating businesses and strategic investments which the Board believes may benefit from being operated as a business unit under Microgen's stewardship. The Board will maintain its prudent approach and there can be no certainty that any material acquisition will be completed.

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Lucy Delaney, FTI Consulting 020-3727-1131

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMLBPTMBTTBFI
Date   Source Headline
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 202410:00 amRNSTotal Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSPDMR Transaction
16th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Oct 20247:00 amRNSTotal Voting Rights
1st Oct 20243:47 pmRNSProposed Board Changes
26th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20247:00 amRNSTransaction in Own Shares
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares
16th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSGrant of awards under 2016 Performance Share Plan
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 202411:40 amRNSTotal Voting Rights
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 20247:00 amRNSTransaction in Own Shares
13th Aug 20247:00 amRNSTransaction in Own Shares
12th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.